Elevated Oxytocin Levels Link to Morbid Jealousy and Partner Violence in Alcohol Dependence
Background
Morbid jealousy, characterized by delusional beliefs of infidelity, is notably more prevalent in alcohol use disorder (AUD) than in primary psychotic disorders, posing significant challenges for patients and their partners. Current treatments often fall short in addressing the complex interplay of neurobiological factors contributing to this severe symptom. Arginine vasopressin (AVP) and oxytocin (OT), both neurohormones released from the posterior pituitary, are crucial for socioemotional functioning, including trust, bonding, and aggression. Disruptions in these systems are implicated in mood and social disorders, suggesting they may play a role in the pathological jealousy observed in AUD.
Study Design
This case-control study investigated the association of arginine vasopressin (AVP) and oxytocin (OT) levels with morbid jealousy in patients with alcohol use disorder. Researchers recruited 28 cases (AUD with morbid jealousy) and 29 controls (AUD without morbid jealousy). Participants were compared on sociodemographic and clinical variables, alongside serum AVP and OT levels. Median AVP and OT levels were compared between the groups, and regression analysis was performed to control for potential confounders such as age and timing of blood sampling.
Results
The study revealed significant differences between groups. Partner violence was substantially more frequent among cases (85.7%) compared to controls (24.1%), with a highly significant P-value of <0.001>. Serum oxytocin levels were also significantly higher in patients with AUD and morbid jealousy. > The median oxytocin level in cases was 69.47 ng/mL (IQR 40.82-97.12), which was significantly greater than the median of 38.75 ng/mL (IQR 26.99-75.11) observed in controls (P = 0.034). This association between elevated oxytocin and morbid jealousy remained significant even after controlling for age and the timing of blood sampling, indicating a robust finding. No significant differences were found in arginine vasopressin levels between the groups.
Why It Matters
This research highlights oxytocin as a potential neurobiological marker for morbid jealousy and associated partner violence in alcohol use disorder. For clinicians, identifying elevated oxytocin levels could help stratify risk and guide more targeted interventions for AUD patients exhibiting morbid jealousy. While this study doesn't offer a direct protocol, it opens avenues for exploring oxytocin system modulation as a therapeutic strategy. Further research is needed to determine if reducing oxytocin levels or modulating its receptor activity could mitigate morbid jealousy and reduce violence, potentially leading to novel treatment approaches beyond current psychiatric care.